Amphotericin B induces trehalose synthesis and simultaneously activates an antioxidant enzymatic response in Candida

Pilar González-Párraga1, Ruth Sánchez-Fresneda, Oscar Zaragoza

  • 1Área de Microbiología, Facultad de Biología, Universidad de Murcia, E-30071, Murcia, Spain.

Abstract

Insights

Trehalose deficiency increases Candida albicans susceptibility to Amphotericin B (AmB). AmB triggers trehalose synthesis and antioxidant responses, highlighting trehalose metabolism as a potential antifungal target.

Area of Science:

  • Mycology
  • Biochemistry
  • Antimicrobial Research

Background:

  • Trehalose metabolism enzymes are potential antifungal targets.
  • Investigating the role of trehalose in Candida albicans resistance to Amphotericin B (AmB).

Purpose of the Study:

  • To analyze the susceptibility of a trehalose-deficient C. albicans mutant (tps1Δ/tps1Δ) to AmB.
  • To understand the mechanisms of C. albicans resistance to AmB, focusing on trehalose accumulation and antioxidant responses.

Main Methods:

  • Culturing and exposing C. albicans strains (wild-type and tps1Δ mutant) to varying AmB doses.
  • Measuring endogenous trehalose levels, antioxidant enzyme activities (catalase, glutathione reductase, superoxide dismutase), and TPS1 mRNA expression via RT-PCR.

Main Results:

  • The tps1Δ mutant showed significantly higher cell death with increasing AmB concentrations compared to the wild-type.
  • AmB induced trehalose synthesis in wild-type cells, linked to TPS1 gene expression and enzyme activity.
  • While AmB activated catalase and glutathione reductase in both strains, no significant differences in activity levels were observed between the mutant and wild-type.

Conclusions:

  • Intracellular trehalose accumulation and induced antioxidant defenses are key mechanisms for C. albicans resistance to AmB.
  • Trehalose synthesis proteins represent a promising antifungal target.
  • AmB induces a multifaceted defense response in C. albicans.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...